|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 371.65 SEK | +5.88% |
|
-0.56% | +13.14% |
| 06-11 | EFN sees buying opportunities in several investment firms, issues sell rating for Öresund | FW |
| 06-11 | Kepler Cheuvreux downgrades Investor to Hold (Buy), raises price target to SEK 403 (385) | FW |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 20.98 | -5.45 | 10.67 | 8.52 | 9.91 | |||||
Return on Total Capital | 21.72 | -5.64 | 11.08 | 8.84 | 10.24 | |||||
Return On Equity % | 39.77 | -11.6 | 19.17 | 14.72 | 17.74 | |||||
Return on Common Equity | 39.86 | -11.6 | 19.23 | 14.76 | 17.77 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 91.81 | 246.06 | 82.95 | 81.51 | 84.62 | |||||
SG&A Margin | 5.37 | -92.81 | 10.94 | 12.32 | 10 | |||||
EBITDA Margin % | 87.07 | 327.14 | 73.3 | 70.52 | 75.29 | |||||
EBITA Margin % | 86.82 | 330.88 | 72.86 | 69.98 | 74.82 | |||||
EBIT Margin % | 86.4 | 338.94 | 71.96 | 69.06 | 74.09 | |||||
Income From Continuing Operations Margin % | 85.86 | 382.53 | 68.43 | 64.02 | 71.55 | |||||
Net Income Margin % | 85.9 | 382.12 | 68.56 | 64.11 | 71.62 | |||||
Net Avail. For Common Margin % | 85.9 | 382.12 | 68.56 | 64.11 | 71.62 | |||||
Normalized Net Income Margin | 53.97 | 235.15 | 43.32 | 40.58 | 45.59 | |||||
Levered Free Cash Flow Margin | 52.83 | 227.41 | 43.04 | 44.43 | 46.63 | |||||
Unlevered Free Cash Flow Margin | 53.32 | 219.45 | 44.22 | 45.81 | 47.78 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.39 | -0.03 | 0.24 | 0.2 | 0.21 | |||||
Fixed Assets Turnover | 31.81 | -2.69 | 23.39 | 19.24 | 21.35 | |||||
Receivables Turnover (Average Receivables) | 6.98 | 7.47 | 7.44 | 7.16 | 6.76 | |||||
Inventory Turnover (Average Inventory) | 3.58 | 3.49 | 3.37 | 3.32 | 3.13 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.51 | 3.43 | 3.21 | 2.98 | 2.94 | |||||
Quick Ratio | 1.87 | 2.68 | 2.37 | 2.38 | 2.15 | |||||
Operating Cash Flow to Current Liabilities | 1.02 | 1.23 | 1.22 | 1.26 | 1.45 | |||||
Days Sales Outstanding (Average Receivables) | 52.32 | 48.88 | 49.05 | 51.09 | 54 | |||||
Days Outstanding Inventory (Average Inventory) | 101.91 | 104.53 | 108.46 | 110.37 | 116.58 | |||||
Average Days Payable Outstanding | 50.55 | 48 | 54.06 | 50.82 | 48.34 | |||||
Cash Conversion Cycle (Average Days) | 103.68 | 105.41 | 103.45 | 110.64 | 122.24 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 12.77 | 15.09 | 12.48 | 12.13 | 12.18 | |||||
Total Debt / Total Capital | 11.32 | 13.11 | 11.09 | 10.82 | 10.86 | |||||
LT Debt/Equity | 12.28 | 14.77 | 11.78 | 11.51 | 11.98 | |||||
Long-Term Debt / Total Capital | 10.89 | 12.83 | 10.48 | 10.27 | 10.68 | |||||
Total Liabilities / Total Assets | 14.08 | 16.39 | 14.43 | 13.9 | 13.5 | |||||
EBIT / Interest Expense | 109.24 | -26.61 | 38.41 | 31.15 | 40.17 | |||||
EBITDA / Interest Expense | 110.29 | -25.47 | 39.31 | 31.96 | 40.97 | |||||
(EBITDA - Capex) / Interest Expense | 108.48 | -27.23 | 38.23 | 30.83 | 40.19 | |||||
Total Debt / EBITDA | 0.38 | -1.44 | 0.66 | 0.79 | 0.7 | |||||
Net Debt / EBITDA | 0.3 | -1.01 | 0.42 | 0.52 | 0.56 | |||||
Total Debt / (EBITDA - Capex) | 0.38 | -1.35 | 0.67 | 0.82 | 0.71 | |||||
Net Debt / (EBITDA - Capex) | 0.3 | -0.95 | 0.43 | 0.54 | 0.57 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 201.27 | -107.36 | -1.05K | -4.61 | 24.4 | |||||
Gross Profit, 1 Yr. Growth % | 265.4 | -119.73 | -419.64 | -6.26 | 29.15 | |||||
EBITDA, 1 Yr. Growth % | 319.38 | -127.68 | -312.39 | -8.15 | 33.22 | |||||
EBITA, 1 Yr. Growth % | 323.45 | -128.08 | -308.73 | -8.31 | 33.42 | |||||
EBIT, 1 Yr. Growth % | 331.43 | -128.9 | -301.26 | -8.39 | 33.9 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 332.88 | -132.8 | -269.63 | -10.76 | 39.03 | |||||
Net Income, 1 Yr. Growth % | 332.02 | -132.75 | -270.12 | -10.79 | 38.96 | |||||
Normalized Net Income, 1 Yr. Growth % | 329.88 | -132.1 | -274.64 | -10.58 | 39.9 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 331.86 | -132.76 | -270.06 | -10.81 | 38.97 | |||||
Accounts Receivable, 1 Yr. Growth % | 6.62 | 30.3 | 4.16 | 15.71 | 2.69 | |||||
Inventory, 1 Yr. Growth % | 25.92 | 41.61 | -4.03 | 14.3 | 5.51 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -32.5 | 16.38 | 2.41 | 29.23 | -1.17 | |||||
Total Assets, 1 Yr. Growth % | 39.31 | -8.95 | 15.75 | 13.55 | 15.83 | |||||
Tangible Book Value, 1 Yr. Growth % | 53.5 | -14.62 | 21.98 | 15.46 | 17.86 | |||||
Common Equity, 1 Yr. Growth % | 47.8 | -11.39 | 18.5 | 14.31 | 16.4 | |||||
Cash From Operations, 1 Yr. Growth % | 29.95 | 16.51 | 26.23 | 12.48 | -6.01 | |||||
Capital Expenditures, 1 Yr. Growth % | 36.36 | 14.98 | -14.81 | 18.79 | -28.12 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 351.29 | -131.72 | -279.43 | -1.46 | 30.97 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 336.47 | -130.32 | -290.99 | -1.08 | 30.14 | |||||
Dividend Per Share, 1 Yr. Growth % | 14.29 | 10 | 9.09 | 8.33 | 7.69 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 35.84 | -52.91 | -16.45 | 200.75 | 8.94 | |||||
Gross Profit, 2 Yr. CAGR % | 42.8 | -15.09 | -20.59 | 73.1 | 10.03 | |||||
EBITDA, 2 Yr. CAGR % | 46.1 | 7.7 | -23.31 | 39.62 | 10.44 | |||||
EBITA, 2 Yr. CAGR % | 46.45 | 8.99 | -23.43 | 38.29 | 10.43 | |||||
EBIT, 2 Yr. CAGR % | 46.82 | 11.61 | -23.72 | 35.74 | 10.58 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 50.06 | 19.15 | -25.41 | 23.03 | 11.39 | |||||
Net Income, 2 Yr. CAGR % | 50.1 | 18.94 | -25.36 | 23.19 | 11.34 | |||||
Normalized Net Income, 2 Yr. CAGR % | 48.42 | 17.42 | -25.11 | 24.92 | 11.79 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 50.05 | 18.95 | -25.36 | 23.16 | 11.33 | |||||
Accounts Receivable, 2 Yr. CAGR % | 8.87 | 17.87 | 16.5 | 9.79 | 9.01 | |||||
Inventory, 2 Yr. CAGR % | 17.34 | 33.54 | 16.58 | 4.74 | 9.82 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -18.48 | -11.37 | 9.18 | 15.04 | 13.01 | |||||
Total Assets, 2 Yr. CAGR % | 23.99 | 12.63 | 2.66 | 14.65 | 14.69 | |||||
Tangible Book Value, 2 Yr. CAGR % | 29.26 | 14.48 | 2.05 | 18.67 | 16.65 | |||||
Common Equity, 2 Yr. CAGR % | 27.38 | 14.44 | 2.47 | 16.39 | 15.35 | |||||
Cash From Operations, 2 Yr. CAGR % | -0.98 | 23.05 | 21.27 | 19.15 | 2.82 | |||||
Capital Expenditures, 2 Yr. CAGR % | 34.82 | 25.21 | -1.03 | 0.59 | -7.6 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 43.34 | 19.59 | -24.55 | 32.92 | 13.43 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 42.53 | 14.99 | -23.89 | 37.4 | 13.29 | |||||
Dividend Per Share, 2 Yr. CAGR % | 33.33 | 12.12 | 9.54 | 8.71 | 8.01 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 87.19 | -48.59 | 28.12 | -12.68 | 124.08 | |||||
Gross Profit, 3 Yr. CAGR % | 165.25 | -26.18 | 32.08 | -16.07 | 57 | |||||
EBITDA, 3 Yr. CAGR % | 314.37 | -16.11 | 35.07 | -18.58 | 37.31 | |||||
EBITA, 3 Yr. CAGR % | 359.55 | -15.58 | 35.36 | -18.71 | 36.5 | |||||
EBIT, 3 Yr. CAGR % | 425.48 | -14.62 | 35.86 | -18.94 | 34.98 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 362.85 | -9.61 | 34.04 | -20.82 | 28.15 | |||||
Net Income, 3 Yr. CAGR % | 366.12 | -9.64 | 34.01 | -20.79 | 28.24 | |||||
Normalized Net Income, 3 Yr. CAGR % | 548.96 | -10.93 | 34.05 | -20.57 | 29.68 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 365.85 | -9.64 | 34 | -20.79 | 28.22 | |||||
Accounts Receivable, 3 Yr. CAGR % | 4.68 | 15.59 | 13.11 | 16.24 | 7.37 | |||||
Inventory, 3 Yr. CAGR % | 12.54 | 24.93 | 19.61 | 15.81 | 4.99 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | -13.69 | -8.21 | -6.99 | 15.49 | 9.36 | |||||
Total Assets, 3 Yr. CAGR % | 24.12 | 11.87 | 13.66 | 6.17 | 15.04 | |||||
Tangible Book Value, 3 Yr. CAGR % | 31.72 | 12.57 | 16.93 | 6.34 | 18.4 | |||||
Common Equity, 3 Yr. CAGR % | 27.74 | 12.87 | 15.78 | 6.28 | 16.39 | |||||
Cash From Operations, 3 Yr. CAGR % | 6.11 | 4.54 | 24.1 | 18.27 | 10.09 | |||||
Capital Expenditures, 3 Yr. CAGR % | 28.85 | 27.85 | 10.13 | 5.18 | -10.07 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 310.22 | -13.33 | 36.92 | -17.55 | 32.13 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 441.85 | -14.94 | 36.19 | -16.96 | 34.8 | |||||
Dividend Per Share, 3 Yr. CAGR % | 7.17 | 25.05 | 11.1 | 9.14 | 8.37 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 33.68 | -24.35 | 35.56 | 4.2 | 20.07 | |||||
Gross Profit, 5 Yr. CAGR % | 42.09 | -3.27 | 63.74 | 3.81 | 22.78 | |||||
EBITDA, 5 Yr. CAGR % | 45.52 | 5.81 | 110.98 | 2.86 | 24.6 | |||||
EBITA, 5 Yr. CAGR % | 46 | 6.39 | 124.36 | 2.85 | 24.76 | |||||
EBIT, 5 Yr. CAGR % | 46.11 | 7.09 | 142.78 | 2.78 | 25.1 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 46.6 | 11.03 | 123.01 | 2.25 | 24.47 | |||||
Net Income, 5 Yr. CAGR % | 46.61 | 11 | 124.02 | 2.29 | 24.44 | |||||
Normalized Net Income, 5 Yr. CAGR % | 46.38 | 10.53 | 173.54 | 1.97 | 24.64 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 46.56 | 10.99 | 123.95 | 2.27 | 24.43 | |||||
Accounts Receivable, 5 Yr. CAGR % | 6.48 | 11.67 | 9.26 | 13.23 | 11.45 | |||||
Inventory, 5 Yr. CAGR % | 17 | 23.44 | 14.14 | 16.42 | 15.59 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | -4.22 | -3.12 | -5.18 | 0.47 | 0.54 | |||||
Total Assets, 5 Yr. CAGR % | 16.55 | 12.13 | 15.05 | 12.97 | 14.07 | |||||
Tangible Book Value, 5 Yr. CAGR % | 19 | 12.1 | 18.94 | 14.97 | 16.82 | |||||
Common Equity, 5 Yr. CAGR % | 17.87 | 12.46 | 16.96 | 14.26 | 15.61 | |||||
Cash From Operations, 5 Yr. CAGR % | 3.06 | 8.86 | 11.93 | 10.15 | 15.1 | |||||
Capital Expenditures, 5 Yr. CAGR % | 19.71 | 25.97 | 15.94 | 16.16 | 2.66 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 47.17 | 9.08 | 108.35 | 2.84 | 26.97 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 46.14 | 7.6 | 147.08 | 3.05 | 26.5 | |||||
Dividend Per Share, 5 Yr. CAGR % | 7.78 | 7.96 | 8.11 | 18.24 | 9.86 |
- Stock Market
- Stocks
- INVE A Stock
- 0NC5 Stock
- Financials Investor AB
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















